Sign in
Single Intraoperative Subconjunctival Triamcinolone Acetonide Injection Versus 4-6-Week Topical Steroid Taper Following Vitreoretinal Surgery
Elizabeth A Atchison, MD
Annual Meeting Talks
2018
Percentage of Patients Maintained on Quarterly Anti-VEGF Dosing for the Treatment of Neovascular Age-Related Macular Degeneration Across Key Clinical Trials
David A. Eichenbaum, MD, FASRS
Heads-Free!: 3D Head-Mounted Display System for Vitreoretinal Surgery
Murat Oncel, MD, FASRS
Category: Practice Management